Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that the U.S. Food and Drug Administration (FDA) granted marketing authorization of the MISHA™ Knee System, an implantable shock absorber (ISA) for the knee. […]
Researchers at the University of Birmingham, working in partnership with design software specialists Autodesk, Manufacturing Technology Centre, and the University Hospitals Birmingham have used a technique called Generative Design to produce a knee implant that can be used to treat osteoarthritis. […]
Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced $40 million in Series C equity and debt financing. […]
(MedTech Intelligence) – A notable uptick in the incidence of orthopedic injuries and musculoskeletal disorders means that the global joint reconstruction devices industry will witness significant growth prospects over the next few years. […]
A groundbreaking new treatment that uses 3D printed implants and that could bring relief to tens of thousands of knee osteoarthritis sufferers has received approval to be trialled in UK patients, following a virtual “in-silico” trial that demonstrated its safety. […]
CyMedica Orthopedics, a leading therapy-based digital health innovator, today announced the U.S. Food and Drug Administration (FDA) has cleared the submission of its latest technology for the management of knee osteoarthritis pain, IntelliHab. […]
Copyright © 2023 | MH Magazine WordPress Theme by MH Themes